New Report
The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
This Report is the pharmaceutical and biotech industry’s standard reference work on royalty rates, published annually by PharmaVentures, the experts in deals and alliances, now online and fully interactive. The 2012 Report presents major new case studies, and provides full, new data and analysis based on data from the premier agreements database, PharmaDeals v4, and other sources. Topics include Royalties and Deal Structures, Sales Milestones, Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication.